C. Mazzarelli

发表

M. Caremani, L. Lapini, D. Tacconi, 2013, Journal of Ultrasound.

Implementation of the frailty assessment to improve liver transplant outcomes

C. Mazzarelli, Mattia Corradi, M. Cesari, 2022, Aging Clinical and Experimental Research.

Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD)

R. Grasso, P. Gallo, G. Luppi, 2014, Archives of medical science : AMS.

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.

A. Gasbarrini, A. Andrealli, P. Angeli, 2020, Journal of hepatology.

Heart failure and chronic kidney disease in a registry of internal medicine wards

C. Mussi, L. Fenoglio, M. Barbagallo, 2014 .

Cost‐Effectiveness of New Direct‐Acting Antivirals to Prevent Post–Liver Transplant Recurrent Hepatitis

G. Cesana, P. Cortesi, L. Mantovani, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience

L. Pani, U. Visco-Comandini, P. Caraceni, 2018, Liver international : official journal of the International Association for the Study of the Liver.

M. Puoti, A. Lauterio, C. Mazzarelli, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection.

D. D’Avola, P. Gallo, G. Dicuonzo, 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Implementation of the frailty assessment to improve liver transplant outcomes

C. Mazzarelli, Mattia Corradi, M. Cesari, 2022, Aging Clinical and Experimental Research.

AISF position paper on HCV in immunocompromised patients

R. Bruno, B. Daniele, P. Lampertico, 2019, Digestive and Liver Disease.

Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge.

G. Perrone, P. Gallo, A. Afeltra, 2011, World journal of gastroenterology.

Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma

R. Sacco, G. Cabibbo, F. Trevisani, 2022, Journal of clinical medicine.

Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

S. Okolicsanyi, M. Strazzabosco, L. Cesarini, 2017, Journal of hepatology.

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.

A. Mancuso, C. Mazzarelli, G. Perricone, 2014, Journal of hepatology.

Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations.

R. Grasso, P. Gallo, A. Afeltra, 2011, The American journal of the medical sciences.

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation

A. Casadei‐Gardini, G. Song, M. Ryu, 2022, Cancer medicine.

Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion‐acquired HCV infection

C. Tinelli, A. Mangia, E. Silini, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Palliative care in end‐stage liver disease: Time to do better?

M. Heneghan, K. Agarwal, C. Mazzarelli, 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients.

N. Heaton, M. Heneghan, K. Agarwal, 2020, Transplantation proceedings.

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

A. Alberti, G. Guaraldi, M. Persico, 2019, Scientific Reports.

Autoimmunity after liver transplantation: a frequent event but a rare clinical problem

D. Fanti, C. Mazzarelli, R. Viganò, 2015, Clinical transplantation.

Focal splenic lesions: US findings M. CaremaniU. OcchiniA. Caremani • D. TacconiL. LapiniA. Accorsi •

C. Mazzarelli, 2013 .

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

A. Gasbarrini, A. Andrealli, P. Angeli, 2018, The Lancet.

Hepatocellular Carcinoma as a Complication of Vascular Disease of the Liver After Fontan Procedure

N. Heaton, M. Hudson, A. Quaglia, 2018, Hepatology.

Pre-emptive post-transplant HCV treatment with IFN-free DAA: Preliminary results from a pilot study

L. Carlis, C. Mazzarelli, R. Viganò, 2016 .

Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre‐ to post‐liver transplant: a real‐life strategy

G. Pieri, P. Caraceni, I. Lenci, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD

S. Morini, G. Perrone, C. Mazzarelli, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Delisting HCV‐infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting

R. Facchetti, P. Cortesi, C. Duvoux, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study

A. Gasbarrini, M. Merli, G. Addolorato, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The optimal timing of hepatitis C therapy in liver transplant‐eligible patients: Cost‐effectiveness analysis of new opportunities

R. Facchetti, G. Cesana, P. Cortesi, 2018, Journal of Viral Hepatitis.

Efficacy and Tolerability of Direct‐Acting Antivirals for Hepatitis C in Older Adults

K. Childs, K. Agarwal, G. Dusheiko, 2018, Journal of the American Geriatrics Society.

Change of liver transplantation list composition: Pre versus post direct-acting antivirals era. The Niguarda Hospital experience.

C. Mazzarelli, R. Viganò, G. Perricone, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The percentage of patients with HCV infection in need of a liver transplant is rapidly declining while their survival after transplantation is improving: A study based on European liver transplant registry

R. Facchetti, P. Cortesi, M. Strazzabosco, 2018 .

Computed Tomography and Magnetic Resonance Imaging Signs of Chronic Liver Rejection: A Case-Control Study.

L. Carbonaro, C. Mazzarelli, A. Vanzulli, 2023, Journal of computer assisted tomography.

Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything.

K. Agarwal, C. Mazzarelli, L. Belli, 2017, Journal of hepatology.

Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post‐transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study

U. Visco-Comandini, G. Guaraldi, I. Lenci, 2018, Clinical transplantation.

Distortion-Product Otoacoustic Emissions: A Useful Test for Monitoring Ototoxicity Induced by Pegylated Interferon and Ribavirin Treatment in Patients with Chronic Hepatitis C

C. Mazzarelli, F. Salvinelli, G. Galati, 2012, International journal of immunopathology and pharmacology.

Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study.

L. Fenoglio, M. Barbagallo, G. Paolisso, 2014, European journal of internal medicine.

The Rising Tide of Nonalcoholic Fatty Liver Disease: How Much Time Until the Flood Reaches Our Coast?

C. Mazzarelli, R. Viganò, D. Angrisani, 2020, Clinical Gastroenterology and Hepatology.

Cost‐Effectiveness of New Direct‐Acting Antivirals to Prevent Post–Liver Transplant Recurrent Hepatitis

C. Mazzarelli, A. Ciaccio, P. Cortesi, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

AISF position paper on HCV in immunocompromised patients.

R. Bruno, B. Daniele, P. Lampertico, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prognostic Scores for Ursodeoxycholic Acid-Treated Patients Predict Graft Loss and Mortality in Recurrent Primary Biliary Cholangitis after Liver Transplantation.

A. Floreani, P. Trivedi, C. Corpechot, 2024, Journal of hepatology.

Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age.

D. D’Avola, C. Mazzarelli, F. Bambacioni, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.